The TGF-β signaling pathway serves as a pro-tumorigenic signal, triggering the manifestation of aggressive tumor characteristics, such as epithelial-mesenchymal transition (EMT), remodeling of the tumor microenvironment, and immune evasion by cancer cells [29–31]. This evidence concerns the gene TGFB1 and cancer.